U.S. 503B Compounding Pharmacies Companies and Market Growth
- SCA Pharma
- Nephron Pharmaceuticals Corporation
- Athenex, Inc.
- Wells Pharma of Houston LLC
- Olympia Pha rmacy
- Fagron Compounding Pharmacies
Company Profile
| Company | Headquarter | Estimated Annual Revenue | Year of Established |
| SCA Pharma | Little Rock, Arkansas, USA | $115 million | 2010 |
| Nephron Pharmaceuticals Corporation | West Columbia, South Carolina, USA | $208 million | 2001 |
| Athenex, Inc. | Buffalo, New York, USA | $117 million | 2003 |
| Wells Pharma of Houston LLC | Houston, Texas, USA | $13.9 million | |
| Olympia Pharmacy | Orlando, Florida, USA | $30.6 million | 2009 |
| Fagron Compounding Pharmacies | Nazareth, Belgium / Rotterdam, Netherlands | $283 million | 1990 |
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking